BioAtla Investor

BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform.

Invests into

Technology: Cancer
Industry: PharmTech
Headquarters: San Diego, California, United States
Founded Date: 2007-01-01
Employees Number: 51-100
Funding Status: IPO
Estimated Revenue: $10M to $50M

Visit Website
info@bioatla.com
Register and Claim Ownership